Top compounds associated with response to SNX20


Feature Type Standardized
Nominal ANOVA
mRNA ATRA CTRPv2 pan-cancer AAC 0.33 1e-14
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.3 6e-13
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.3 2e-12
mRNA CAL-101 GDSC1000 pan-cancer AAC 0.26 4e-12
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.31 5e-12
mRNA linifanib CTRPv2 pan-cancer AAC 0.28 1e-10
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.4 2e-10
mRNA quizartinib CTRPv2 pan-cancer AAC 0.28 5e-10
mRNA AC220 GDSC1000 pan-cancer AAC 0.25 5e-09
mRNA momelotinib CTRPv2 pan-cancer AAC 0.25 5e-09
Download CSV